InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
无可用的信号评分。
Explore the full record of transactions filed by FitzPatrick Margaret M. Officer active across 1 company, notably AN2 Therapeutics, Inc.. Aggregated, 2 disclosures have been recorded. Split: 2 buys · 0 sell. Total volume traded: €19k. Activity tracked since 28 May 2025. The latest transaction was disclosed on 1 September 2026 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 条申报中的 2 条